A tool to automatically detect and outline brain tumors from MRI scans
A clinical tool for automated detection and delineation of intracranial metastases from MRI
This study is testing a new AI tool that helps doctors find and outline small brain tumors in MRI scans more accurately, making it easier for them to plan treatment for patients with brain metastases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10884465 on NIH RePORTER |
What this research studies
This research focuses on developing an artificial intelligence (AI) tool that can automatically detect and outline small metastatic brain tumors in 3D MRI scans. By utilizing advanced neural network technology, the project aims to enhance the accuracy and efficiency of radiologists and radiation oncologists in identifying and managing multiple brain metastases. The AI system will be trained on clinical images from patients who have undergone treatment for brain metastases, ensuring that it is tailored to real-world scenarios. The ultimate goal is to improve treatment planning and patient outcomes through better detection and delineation of these tumors.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with multiple small metastatic tumors in the brain who are undergoing treatment.
Not a fit: Patients without brain metastases or those with very large, easily detectable tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely detection of brain metastases, improving treatment strategies and patient outcomes.
How similar studies have performed: Previous research has shown promising results in using AI for medical imaging, indicating potential success for this novel approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Cao, Yue — University of Michigan at Ann Arbor
- Study coordinator: Cao, Yue
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.